SCHEMBL359218

SCHEMBL359218

CC(=O)Cc1ccccc1[N+](=O)[O-]

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.59
MEN1 O00255 5/20 0.59
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
ALDH1A1 P00352 5/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
TSHR P16473 1/20 0.56
CYP2C19 P33261 2/20 0.56
POLB P06746 1/20 0.56
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
MAOB P27338 1/20 0.54
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.51
MAPT P10636 1/20 0.50
SIGMAR1 Q99720 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31046181 1.00 KMT2A (0.59) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL15395529 0.87 KMT2A (0.57) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL7498880 0.87 ALDH1A1 (0.58) KMT2AMEN1NPC1RAB9ASMN1; SMN2
Acetic Acid SCHEMBL9323112 0.86 CYP1A2 (0.57) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL13689727 0.85 ALDH1A1 (0.56) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL9889547 0.85 KMT2A (0.52) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL8586329 0.85 ALDH1A1 (0.61) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL15887327 0.84 GPR35 (0.58) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL10752489 0.84 ALDH1A1 (0.55) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL5692150 0.83 ALDH1A1 (0.59) KMT2AMEN1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820121-A Synthesis process of 2-nitrophenoxy acetone 威尔(福建)生物有限公司 2024-04-05 CN claimed
CN-101468964-B Processes for producing indole compound NISSAN CHEMICAL IND LTD 2011-05-11 CN claimed
CN-100577659-C Processes for producing indole compound NISSAN CHEMICAL IND LTD 2010-01-06 CN claimed
CN-101468964-A Processes for producing indole compound NISSAN CHEMICAL IND LTD (JP) 2009-07-01 CN claimed
CN-1896075-A Processes for producing indole compound NISSAN CHEMICAL IND LTD (JP) 2007-01-17 CN claimed
CN-1286832-C Process for producing indole compound NISSAN CHEMICAL IND LTD (JP) 2006-11-29 CN claimed
CN-1646522-A Process for producing indole compound NISSAN CHEMICAL IND LTD (JP) 2005-07-27 CN claimed
CN-117820121-A Synthesis process of 2-nitrophenoxy acetone 威尔(福建)生物有限公司 2024-04-05 CN disclosed
WO-2023214935-A1 PROCESS FOR PREPARING RELUGOLIX AND INTERMEDIATES THEREOF SCINOPHARM TAIWAN, LTD. (TW) 2023-11-09 WO disclosed
US-20230357267-A1 PROCESS FOR PREPARING RELUGOLIX AND INTERMEDIATES THEREOF SCINOPHARM TAIWAN, LTD. (TW) 2023-11-09 US disclosed
WO-2021047166-A1 METHOD FOR SYNTHESIZING TRANYLCYPROMINE INTERMEDIATE 凯特立斯(深圳)科技有限公司 2021-03-18 WO disclosed
CN-108203385-B Method for preparing 3- (4-fluoro-2-nitrophenyl) acetone 青岛恒宁生物科技有限公司 2021-03-09 CN disclosed
CN-109311920-A The method for preparing phosphoric acid diamides morpholino oligomers 萨勒普塔医疗公司 2019-02-05 CN disclosed
US-4514214-A Herbicidal sulfamates E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-04-30 US disclosed
US-4511392-A N--/PYRIMIDIN-2-YLAMINOCARBENYL/-HETERO-SUBSTITUETED BENZENSESULFO E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-04-16 US disclosed
US-4475944-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-10-09 US disclosed
EP-0096593-A2 Herbicidal sulfamates E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-12-21 EP disclosed
EP-0083975-A2 Herbicidal sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-07-20 EP disclosed
US-3979410-A Intermediate α-acyl-β-dialkylamino-2-nitrostyrenes HOFFMANN-LA ROCHE INC. (US) 1976-09-07 US disclosed
US-3931225-A Process for preparing o-nitrobenzylketones HOFFMANN-LA ROCHE INC. (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357267-A1 PROCESS FOR PREPARING RELUGOLIX AND INTERMEDIATES THEREOF PRMT8, PRMT7, PRMT1 KMT2A 166/4885MEN1 306/4885NPC1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.